Filtered By:
Infectious Disease: Hepatitis C
Procedure: Hemodialysis
This page shows you your search results in order of date.
Order by Relevance | Date
Total 822 results found since Jan 2013.
High Prevalence of Occult Hepatitis B Virus Infection among Iranian Hemodialysis Patients
Am J Trop Med Hyg. 2023 Mar 13:tpmd220345. doi: 10.4269/ajtmh.22-0345. Online ahead of print.ABSTRACTConsidering the potential risks associated with occult hepatitis B virus (HBV) infection, this study was designed to investigate the magnitude and genotypic pattern of occult HBV infection among hemodialysis patients. All patients on regular hemodialysis attending the dialysis centers located in southern Iran and 277 nonhemodialysis controls were invited to participate in this study. Serum samples were tested for detection of hepatitis B core antibody (HBcAb) and hepatitis B surface antigen (HBsAg) by competitive enzyme imm...
Source: Am J Trop Med Hyg - March 13, 2023 Category: Infectious Diseases Authors: Fatemeh Farshadpour Reza Taherkhani Athar Shahabi Source Type: research
The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis
CONCLUSIONS: HCV infection among hemodialysis patients is a worldwide shared burden and is associated with a higher risk of death. Avoiding unnecessary blood transfusion and dialyzer reuse should be encouraged to prevent HCV transmission in hemodialysis units.PMID:36383211 | DOI:10.1007/s40620-022-01483-x
Source: Journal of Nephrology - November 16, 2022 Category: Urology & Nephrology Authors: Primploy Greeviroj Tanat Lertussavavivat Thana Thongsricome Kullaya Takkavatakarn Jeerath Phannajit Yingyos Avihingsanon Kearkiat Praditpornsilpa Somchai Eiam-Ong Paweena Susantitaphong Source Type: research
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
CONCLUSIONS: DAAs shows comparable SVR12 and safety in CKD patients (stage 3, 4, and 5) with HCV compared with patients with stage 1 and 2. The effectiveness and safety of DAAs may be related to the treatment duration. Therefore, it is important to select adequate regimens of DAAs and to increase treatment adherence.PMID:35981893 | DOI:10.3904/kjim.2021.486
Source: The Korean Journal of Internal Medicine - August 18, 2022 Category: Internal Medicine Authors: Ji Eun Ryu Myeong Jun Song Seok-Hwan Kim Jung Hyun Kwon Sun Hong Yoo Soon Woo Nam Hee Chul Nam Hee Yeon Kim Chang Wook Kim Hyun Yang Si Hyun Bae Do Seon Song U Im Chang Jin Mo Yang Sung Won Lee Hae Lim Lee Soon Kyu Lee Pil Soo Sung Jeong Won Jang Jong You Source Type: research
